Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abvc Biopharma (ABVC) Net Income (2016 - 2025)

Historic Net Income for Abvc Biopharma (ABVC) over the last 14 years, with Q3 2025 value amounting to -$1.3 million.

  • Abvc Biopharma's Net Income fell 16414.47% to -$1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.4 million, marking a year-over-year decrease of 384.0%. This contributed to the annual value of -$5.3 million for FY2024, which is 3649.15% up from last year.
  • Latest data reveals that Abvc Biopharma reported Net Income of -$1.3 million as of Q3 2025, which was down 16414.47% from -$2.3 million recorded in Q2 2025.
  • Abvc Biopharma's 5-year Net Income high stood at -$487431.0 for Q3 2024, and its period low was -$6.9 million during Q4 2021.
  • In the last 5 years, Abvc Biopharma's Net Income had a median value of -$1.9 million in 2022 and averaged -$2.4 million.
  • Its Net Income has fluctuated over the past 5 years, first plummeted by 40928.62% in 2022, then soared by 8552.79% in 2024.
  • Over the past 5 years, Abvc Biopharma's Net Income (Quarter) stood at -$6.9 million in 2021, then soared by 34.78% to -$4.5 million in 2022, then surged by 84.44% to -$700309.0 in 2023, then decreased by 13.74% to -$796527.0 in 2024, then crashed by 61.64% to -$1.3 million in 2025.
  • Its last three reported values are -$1.3 million in Q3 2025, -$2.3 million for Q2 2025, and -$944190.0 during Q1 2025.